Med BioGene seeks U.S. listing

Med BioGene Inc. (TSX-V:MBI) proposed to list its shares on NASDAQ and raise up to $24.3 million in a follow-on underwritten by Rodman. The company also announced that it raised C$700,000 ($667,000) through the sale of 5.8 million units at C$0.12 in a private placement. Med BioGene plans to implement a 1-for-50 reverse stock split of its common shares prior to listing in the U.S. ...